Palantir Technologies (NASDAQ: PLTR) Price Prediction and Forecast 2025-2030 for May 26 — Negative
PLTR 24/7 Wall Street — May 26, 2025Shares of Palantir Technologies Inc. (NASDAQ:PLTR) were mostly flat over the past five trading sessions, falling by 0.10%.

Best Natural and Organic Food Stocks to Keep an Eye On in 2025 — Positive
BYND GIS SFM UNFI Zacks Investment Research — May 26, 2025Sprouts Farmers, United Natural, Beyond Meat and General Mills are betting big on organic, clean-label foods and redefining what's healthy on store shelves.

Dycom Jumps 39% in 3 Months: Should You Buy, Sell or Hold the Stock? — Positive
DY Zacks Investment Research — May 26, 2025DY gains from fiber-to-the-home programs and hyperscaler projects, offsetting macro and tariff headwinds with strong long-term growth visibility.

Merck (NYSE:MRK) stock has experienced a significant 22% decline this year, sharply underperforming the broader S&P 500 index, which is down only 1%. This downturn can be attributed to several factors: a lowered guidance for 2025 and growing concerns about the long-term growth prospects of its blockbuster drugs, Keytruda and Gardasil.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI — Neutral
TMCI Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST — Neutral
WST Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DV — Neutral
DV Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than July 21, 2025.

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Open Lending Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LPRO — Neutral
LPRO Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: New York, N.Y., May 26, 2025.

Gorilla Pops 14.6% on Buyback Completion: Should You Buy GRRR Now? — Positive
GRRR Zacks Investment Research — May 26, 2025GRRR rallies after completing $5.4M in buybacks and lifting insider ownership to 20%, with 2025 growth and margins tracking higher.

Wix Acquires Hour One to Boost Generative AI and Drive Innovation — Positive
WIX Zacks Investment Research — May 26, 2025WIX acquires Hour One to scale AI media creation, boost immersive web design and cut reliance on third parties for front-end innovation.

Cautious Optimism in Gap's Pre-Q1 Earnings: Buy or Hold for Now? — Positive
GAP Zacks Investment Research — May 26, 2025GAP expects modest Q1 growth, margin expansions and brand momentum, with cost controls helping offset macro and tariff headwinds in the upcoming report.

CrowdStrike: Don't Chase, As Q1 Results Are Unlikely To Be Stellar — Positive
CRWD Seeking Alpha — May 26, 2025CrowdStrike has outperformed both the market and cybersecurity peers quite handsomely this year, with the sustainability of this alpha likely to be dictated by Q1 earnings on the 3rd of June. The pace of sales growth is expected to dip even further, but the decline in new ARR may not be as bad as what was seen in H2-25. CRWD is due to face pressure on the operational margin front, as it ramps up investments and incurs one-off costs.

MercadoLibre Rises 47% YTD: Should You Buy, Sell or Hold the Stock? — Neutral
MELI Zacks Investment Research — May 26, 2025MELI surges 47% YTD on strong earnings and user growth, but credit risks and fierce competition prompt a cautious hold recommendation.

The New York Times Company Leverages Digital Subscriptions for Growth — Positive
NYT Zacks Investment Research — May 26, 2025NYT adds 11.06M digital-only subscribers in Q1, lifting digital revenues by 14.4% and boosting ARPU to $9.54, as it navigates away from declining print.

TOP RANKED ROSEN LAW FIRM Encourages Backblaze, Inc. Investors to Inquire About Securities Class Action Investigation - BLZE — Neutral
BLZE Accesswire — May 26, 2025WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ:BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Backblaze securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Investors in BigBear.ai Holdings, Inc. (BBAI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025 — Neutral
BBAI Accesswire — May 26, 2025NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=150244&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

ROSEN, A LEADING LAW FIRM, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BITF — Neutral
BITF Accesswire — May 26, 2025NEW YORK, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. (NASDAQ:BITF) between March 21, 2023 and December 9, 2024, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff.

When It Rains Gold, Put Out The Bucket: 2 Wonderful Income Bargains — Positive
BMY REXR Seeking Alpha — May 26, 2025Focus on high-quality, dividend-paying stocks with temporary setbacks, offering both value and income for patient investors. Bristol-Myers Squibb is deeply undervalued, carries a 5.3% yield, strong profitability, and a promising neurodegenerative drug pipeline. Rexford Industrial Realty offers a 5% yield, benefits from supply-constrained Southern California industrial markets, and trades far below historical valuation.

CGC DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CGC — Neutral
CGC Accesswire — May 26, 2025NEW YORK, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ:CGC) between May 30, 2024 and February 6, 2025, both dates inclusive (the "Class Period"), of the important June 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Canopy Growth securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Abercrombie Shows Uncertainty Before Q1 Earnings: Buy Now or Step Back? — Negative
ANF Zacks Investment Research — May 26, 2025ANF eyes modest Q1 revenue growth, but earnings dip, cost pressures and tariff risks cloud near-term outlook ahead of the May 28 earnings release.
